Risk factors for unsuccessful medical abortion with mifepristone and misoprostol

References

• Ashok PW, Penney GC, Flett GM, Templeton A. An effective regimen for early medical abortion: a report of 2000 consecutive cases. Hum Reprod. 1998; 13: 2962–5
   PubMed Web of Science ®Google Scholar
• Ashok PW, Templeton A, Wagaarachchi PT, Flett GM. Factors affecting the outcome of early medical abortion: a review of 4132 consecutive cases. BJOG. 2002; 109: 1281–9
   PubMed Web of Science ®Google Scholar
• Spitz IM, Bardin CW, Benton L, Robbins A. Early pregnancy termination with mifepristone and misoprostol in the United States. N Engl J Med. 1998; 338: 1241–7
   PubMed Web of Science ®Google Scholar
• Rorbye C, Norgaard M, Vestermark V, Nilas L. Medical abortion. Defining success and categorizing failures. Contraception. 2003; 68: 247–51
   PubMed Web of Science ®Google Scholar
• Kulier R, Gulmezoglu A, Hofmeyr G, Cheng L, Campana A. Medical methods for first trimester abortion. Cochrane Database Syst Rev. 2004; 1: CD002855
   Google Scholar
• Winikoff B, Ellertson C, Elul B, Sivin I. Acceptability and feasibility of early pregnancy termination by mifepristone-misoprostol. Results of a large multicenter trial in the United States. Mifepristone Clinical Trials Group. Arch Fam Med. 1998; 7: 360–6
   PubMedGoogle Scholar
• Rossi B, Creinin MD, Meyn LA. Ability of the clinician and patient to predict the outcome of mifepristone and misoprostol medical abortion. Contraception. 2004; 70: 313–7
   PubMed Web of Science ®Google Scholar
• Paul M, Schaff E, Nichols M. The roles of clinical assessment, human chorionic gonadotrophin assays, and ultrasonography in medical abortion practice. Am J Obstet Gynecol 2000; 183(suppl)34–43
   PubMed Web of Science ®Google Scholar
• Harwood B, Meckstroth KR, Mishell DR, Jain JK. Serum beta-human chorionic gonadotrophin levels and endometrial thickness after medical abortion. Contraception. 2001; 63: 255–6
   PubMed Web of Science ®Google Scholar
• Cowett AA, Cohen LS, Lichtenberg ES, Stika CS. Ultrasound evaluation of the endometrium after medical termination of pregnancy. Obstet Gynecol. 2004; 103: 871–5
   PubMed Web of Science ®Google Scholar
• Creinin MD, Harwood B, Guido RS, Fox MC, Zhang J. NICHD Management of Early Pregnancy Failure Trial. Int J Gynaecol Obstet. 2004; 86: 22–6
   PubMed Web of Science ®Google Scholar
• Luise C, Jermy K, Collons WP, Bourne TH. Expectant management of incomplete, spontaneous first-trimester miscarriage: outcome according to initial ultrasound criteria and value of follow-up visits. Ultrasound Obstet Gynecol. 2002; 19: 580–2
   PubMed Web of Science ®Google Scholar
• Fielding SL, Schaff EA, Nam NY. Clinicians’ perception of sonogram indication for mifepristone abortion up to 63 days. Contraception. 2002; 66: 27–31
   PubMed Web of Science ®Google Scholar
• Fiala C, Safar P, Bygdeman M, Gemzell-Danielsson K. Verifying the effectiveness of medical abortion; ultrasound versus hCG testing. Eur J Obstet Gynecol Reprod Biol. 2003; 109: 190–5
   PubMed Web of Science ®Google Scholar
• Acharya G, Haugen M, Brathen A, Nilsen I, Maltau JM. Role of routine ultrasonography in monitoring the outcome of medical abortion in a clinical setting. Acta Obstet Gynecol Scand. 2004; 83: 390–4
   PubMed Web of Science ®Google Scholar
• Rorbye C, Norgaard M, Nilas L. Prediction of late failure after medical abortion from serial beta-hCG measurements and ultrasonography. Hum Reprod. 2004; 19: 85–9
   PubMed Web of Science ®Google Scholar
• Bartley J, Tong S, Everington D, Baird DT. Parity is a major determinant of success rate in medical abortion: a retrospective analysis of 3161 consecutive cases of early medical abortion treated with reduced doses of mifepristone and vaginal gemeprost. Contraception. 2000; 62: 297–303
   PubMed Web of Science ®Google Scholar
• Grossman D, Ellertson C, Grimes DA, Walker D. Routine follow-up visits after first-trimester induced abortion. Obstet Gynecol. 2004; 103: 738–45
   PubMed Web of Science ®Google Scholar
• Honkanen H, Ranta S, Ylikorkala O, Heikinheimo O. The kinetics of serum hCG and progesterone in response to oral and vaginal administration of misoprostol during medical termination of early pregnancy. Hum Reprod. 2002; 17: 2315–9
   PubMed Web of Science ®Google Scholar